In this episode, David Flores speaks with Matt Zemon, the co-founder of Happy and author of Psychedelic for Everyone. David and Matt open up about personal stories about their childhood, with Matt sharing a beautiful story about connecting with his son Cole.
Similar Posts
Interview With Douglas K. Gordon
CEO of Silo Wellness, Douglas K. Gordon, speaks about the company’s expansion to the Frankfurt Exchange and the recent collaboration with the Bob Marley Estate.
Interview With James Hallifax
In this episode of the Psychedelic Spotlight podcast, we feature James Hallifax, Co-Founder of The Psychedelic Investor.
Changing Lives Through Psychedelic-Assisted Therapy – Healing Souls
In today’s episode, we talk with Dr. Ryan Westrum, the founder and visionary of Healing Souls, a practice dedicated to changing the way individuals, couples and families look at counseling.
Exploring Healing and Embodiment: Insights from The Body Workshop
In a world where wellness encompasses more than just physical health, The Body Workshop offers a unique platform for exploring the interconnectedness of mind, body, and spirit.
Mixing Psychedelics & Antidepressants: Is it Safe? | NEW Psilocybin Study
As using psychedelics as medicines for mental health conditions has become more popular, it has been an open question of whether substances such as psilocybin (magic mushrooms) can safely be combined with anti-depressants such as SSRIs.
Now, Compass Pathways (CMPS) has released a small study, which showed that it is in fact safe to combine the two drugs. This is the second such small study to come to this conclusion. Earlier this year, MindMed, (MNMD / MMED) had released data on a similar study, with similar results
However, it is important to note that these are two very small studies, and that nothing has been definitively proven yet.
Many argue that psychedelics like psilocybin should be a replacement for depression medications such as SSRIs, not another layer of medicine. While I am sympathetic to this view, we must ultimately follow the science.
Compass Pathways will use the results of this trial to inform the design of their upcoming phase 3 trial testing whether psilocybin can treat treatment resistant depression.
Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com
Music from:
www.bensound.com
Video editing: @themyaholy
@Psychedelic Spotlight
#psychedelics #antidepressants #psilocybin
Suing the City of Oakland for Mushroom Raid with Dave Hodges
In this episode, Dave speaks to Dennis Walker about how Oakland PD raided his church and confiscated $200,000 worth of sacraments.